[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100650034":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":37,"responsibleParty":64,"collaborators":66,"id":70,"slug":71,"hasResults":72,"nctId":73,"briefTitle":74,"officialTitle":75,"acronym":18,"eligibilityCriteria":76,"healthyVolunteers":72,"sex":77,"minAge":78,"maxAge":18,"enrollmentInfo":79,"targetDuration":18,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":88,"overallStatus":90,"whyStopped":18,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"NYU Langone Health","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Integrated Kidney Palliative Care","EXPERIMENTAL","Participants will receive integrated kidney palliative care (Kidney RISE) in addition to their usual CKD care. The integrated kidney palliative care consists of 4 kidney palliative care (KPC) intervention visits over 24 weeks by a KPC-trained palliative care provider in person or telehealth, each visit will last between 30-60 minutes.",[13],"Behavioral: Kidney RISE",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual Chronic Kidney Disease (CKD) Care","NO_INTERVENTION","Participants in this arm will receive the usual CKD care.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","Kidney RISE","Core components include assessment of symptoms (IPOS-Renal), illness understanding, goals of care, advance care planning, spiritual needs, and screening for health-related social needs (HRSNs) using the validated Centers for Medicare and Medicaid Services (CMS) Accountable Health Communities (AHC) Survey. Plans will address symptom management with evidence-based algorithms, linkage to social or spiritual supports, and shared decision-making appropriate to CKD stage.",[9],[26],{"name":27,"affiliation":5,"role":28},"Jennifer Scherer, MD, MS, FASN","PRINCIPAL_INVESTIGATOR",[30,34],{"name":27,"role":31,"phone":32,"phoneExt":18,"email":33},"CONTACT","212-263-0705","Jennifer.scherer@nyulangone.org",{"name":35,"role":31,"phone":18,"phoneExt":18,"email":36},"Rachel Monahan","Rachel.monahan@nyulangone.org",[38,54],{"facility":39,"status":18,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Emory University","Atlanta","Georgia","30322","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-84.38798,33.749,{"lat":49,"lon":48},[52],{"name":53,"role":28,"phone":18,"phoneExt":18,"email":18},"Dio Kavalieratos, MD",{"facility":5,"status":18,"city":55,"state":55,"zip":56,"country":43,"countryCode":44,"cosmosGeoPoint":57,"geoPoint":61,"contacts":62},"New York","10016",{"type":46,"coordinates":58},[59,60],-74.00597,40.71427,{"lat":60,"lon":59},[63],{"name":27,"role":28,"phone":18,"phoneExt":18,"email":18},{"type":65,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[67],{"name":68,"class":69},"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","NIH","100650034","kidney-rise-randomized-integrated-supportive-care-trial-100650034",false,"NCT07741357","Kidney RISE: Randomized Integrated Supportive CarE Trial","Phase II Multi-Site Randomized Controlled Trial Testing Integrated Kidney Palliative Care Compared With Usual Chronic Kidney Disease Care (Kidney RISE)","Inclusion Criteria:\n\n1. Receive care at nephrology clinics or dialysis centers associated with each site.\n2. Have CKD stage IV, V (eGFR \\\u003C 30 mL\u002Fmin\u002F1.73m2), or be receiving chronic dialysis\n3. Speak Spanish or English, and report at IPOS-Renal score of ≥ 3 on a screening survey.\n4. Willing to be randomized to either study arm and to comply with the study procedures for the assigned group.\n\nExclusion Criteria:\n\n1. Unable to provide informed consent\n2. Has received palliative care (inpatient or outpatient) in the last six months.\n3. Enrolled in hospice\n4. Has any urgent palliative care needs (i.e. severe pain, emotional distress) identified upon screening. Research staff will be trained to recognize these needs.\n5. Non-English and Non-Spanish speakers to correspond with the populations most impacted by CKD in the US.\n6. Pregnant individuals.","ALL","18 Years",{"count":80,"type":81},280,"ESTIMATED","INTERVENTIONAL",[84],"NA","The purpose of study is to investigate whether adding palliative care to usual chronic kidney disease (CKD) care improves symptoms and quality of life for people with CKD. The primary objectives are to 1) determine efficacy of Kidney Palliative Care (KPC) integrated with CKD care on symptom burden compared with usual CKD care, 2) identify clinical and demographic factors associated with differential responses to KPC, and 3) characterize participant and provider experiences with kidney care and factors influencing implementation.",[87],"Chronic Kidney Disease (Stages 4 and 5)",[89],"CKD","NOT_YET_RECRUITING","2026-07-29",{"date":93,"type":94},"2026-08-03","ACTUAL",{"date":96,"type":81},"2027-05",{"date":98,"type":81},"2031-01",{"name":5,"class":6},2]